{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:22:58Z","timestamp":1791087778950,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.peptides.2006.05.004","type":"journal-article","created":{"date-parts":[[2006,6,22]],"date-time":"2006-06-22T07:34:42Z","timestamp":1150961682000},"page":"2600-2606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Experimental study on the efficacy of combination of \u03b1-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides"],"prefix":"10.1016","volume":"27","author":[{"given":"Oscar","family":"Cirioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ghiselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giacometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mocchegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Chiodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese Della","family":"Vittoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Scalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2006.05.004_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/328478a0","article-title":"Antimicrobial peptides. A family of wound healers","volume":"328","author":"Cannon","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2006.05.004_bib2","unstructured":"Clinical and Laboratory Standards Institute (CLSI) 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard M7-A6. Villanova, PA."},{"key":"10.1016\/j.peptides.2006.05.004_bib3","series-title":"Performance standards for antimicrobial disk susceptibility test, approved standard M2-A7","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2003"},{"key":"10.1016\/j.peptides.2006.05.004_bib4","series-title":"Antibiotics in laboratory medicine","first-page":"330","article-title":"Antimicrobial combinations","author":"Eliopoulos","year":"1996"},{"key":"10.1016\/j.peptides.2006.05.004_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/jac\/43.6.846","article-title":"Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf area","volume":"43","author":"Geisel","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0196-9781(99)00131-X","article-title":"Antimicrobial activity of polycationic peptides","volume":"20","author":"Giacometti","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2006.05.004_bib7","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1128\/AAC.46.9.2885-2888.2002","article-title":"Efficacy of quinupristin\/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides","volume":"46","author":"Giacometti","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/AAC.49.3.1249-1252.2005","article-title":"In-vitro activity of histatins derivative P-113 alone and in combination with antimicrobial agents against multidrug-resistant pathogens responsible of pneumonia in immunocompromised patients","volume":"49","author":"Giacometti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","article-title":"Peptide antibiotics","volume":"43","author":"Hancock","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1073\/pnas.97.16.8856","article-title":"The role of antimicrobial peptides in animal defences","volume":"97","author":"Hancock","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2006.05.004_bib11","series-title":"Clinical microbiology procedures handbook","first-page":"5.16.14","article-title":"Tests to assess bactericidal activity","author":"Hindler","year":"1992"},{"key":"10.1016\/j.peptides.2006.05.004_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1432-1033.1980.tb05991.x","article-title":"Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia","volume":"106","author":"Hultmark","year":"1980","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.peptides.2006.05.004_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1203\/00006450-199906000-00001","article-title":"Antimicrobial peptides as mediators of epithelial host defense","volume":"45","author":"Huttner","year":"1999","journal-title":"Pediatr Res"},{"key":"10.1016\/j.peptides.2006.05.004_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2006.05.004_bib16","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AEM.69.3.1797-1799.2003","article-title":"Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria","volume":"69","author":"Luders","year":"2003","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.peptides.2006.05.004_bib17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/jac\/37.6.1077","article-title":"Antimicrobial activity of cecropins","volume":"37","author":"Moore","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib18","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/AAC.47.4.1262-1266.2003","article-title":"Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis","volume":"47","author":"Moore","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib19","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/AAC.43.8.2059","article-title":"In vitro activities of linezolid against important Gram-positive bacterial pathogens including vancomycin-resistant enterococci","volume":"43","author":"Noskin","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijantimicag.2004.09.005","article-title":"Antimicrobial peptides: premises and promises","volume":"24","author":"Reddy","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.peptides.2006.05.004_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3201\/eid0501.990118","article-title":"Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteraemia","volume":"5","author":"Rotun","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.peptides.2006.05.004_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0140-6736(91)93375-J","article-title":"Peritonitis due to vancomycin-resistant Staphylococcus epidermidis","volume":"337","author":"Sanyal","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2006.05.004_bib23","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/IAI.67.4.2005-2009.1999","article-title":"Biological properties of structurally related \u03b1-helical cationic antimicrobial peptides","volume":"67","author":"Scott","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.peptides.2006.05.004_bib24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1006\/bbrc.2001.6234","article-title":"Salt resistance and synergistic effect with vancomycin of \u03b1-helical antimicrobial peptide P18","volume":"290","author":"Shin","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2006.05.004_bib25","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1128\/jb.179.8.2557-2566.1997","article-title":"Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of S. aureus","volume":"179","author":"Sieradzki","year":"1997","journal-title":"J Bacteriol"},{"key":"10.1016\/j.peptides.2006.05.004_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.42.1.100","article-title":"Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci","volume":"42","author":"Sieradzki","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0195-6701(99)90060-9","article-title":"Implications of vancomycin resistant Staphylococcus aureus","volume":"43","author":"Tenover","year":"1999","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.peptides.2006.05.004_bib28","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.87.12.4761","article-title":"All-D amino acid-containing channel-forming antibiotic peptides","volume":"87","author":"Wade","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2006.05.004_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1128\/CMR.8.4.585","article-title":"Current perspectives on glycopeptide resistance","volume":"8","author":"Woodford","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.peptides.2006.05.004_bib30","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/AAC.45.5.1558-1560.2001","article-title":"Synergistic interaction between mammalian antimicrobial defense peptides","volume":"45","author":"Yan","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/AAC.45.4.1244-1248.2001","article-title":"Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics","volume":"45","author":"Zarrouk","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2006.05.004_bib32","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1073\/pnas.84.15.5449","article-title":"Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor","volume":"84","author":"Zasloff","year":"1987","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978106002270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978106002270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:19:30Z","timestamp":1759310370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978106002270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0196978106002270"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2006.05.004","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental study on the efficacy of combination of \u03b1-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2006.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}